What is he best known for?
The fields of study he is best known for:
His main research concerns Virology, Virus, Stereochemistry, Nucleoside and Molecular biology.
His Virology study combines topics in areas such as Nucleoside analogue and Peripheral blood mononuclear cell.
His work focuses on many connections between Virus and other disciplines, such as Cytotoxicity, that overlap with his field of interest in Therapeutic index.
His research integrates issues of Cytosine, Biological activity, In vitro and Purine in his study of Stereochemistry.
His Nucleoside study combines topics from a wide range of disciplines, such as Nucleotide and Pharmacology.
His work deals with themes such as Reverse transcriptase, Cell growth, Polymerase and DNA polymerase, which intersect with Molecular biology.
His most cited work include:
- Polyoxometalates in Medicine (1421 citations)
- A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness (841 citations)
- Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues. (508 citations)
What are the main themes of his work throughout his whole career to date?
Raymond F. Schinazi mostly deals with Virology, Stereochemistry, Nucleoside, Virus and In vitro.
His work carried out in the field of Virology brings together such families of science as Nucleoside analogue, Molecular biology and Reverse transcriptase.
The study incorporates disciplines such as Polymerase, DNA, Mutant and Viral replication in addition to Reverse transcriptase.
His Stereochemistry research integrates issues from Biological activity, Chemical synthesis, Purine and Cytotoxicity.
Raymond F. Schinazi interconnects Prodrug, Pharmacokinetics, Pharmacology and Nucleotide in the investigation of issues within Nucleoside.
His study on Virus is covered under Immunology.
He most often published in these fields:
- Virology (39.01%)
- Stereochemistry (30.35%)
- Nucleoside (28.23%)
What were the highlights of his more recent work (between 2013-2021)?
- Virology (39.01%)
- Nucleoside (28.23%)
- Reverse transcriptase (16.74%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Virology, Nucleoside, Reverse transcriptase, Stereochemistry and Virus.
His research investigates the connection between Virology and topics such as Nucleoside analogue that intersect with issues in Flaviviridae.
Raymond F. Schinazi has researched Nucleoside in several fields, including Prodrug, Pharmacology, Polymerase and Molecular biology.
His Reverse transcriptase research incorporates elements of Potency and DNA replication.
His study looks at the relationship between Stereochemistry and topics such as EC50, which overlap with Pharmacology toxicology and Anti hiv 1.
His Dengue fever research extends to Virus, which is thematically connected.
Between 2013 and 2021, his most popular works were:
- Zika Virus Infects Human Placental Macrophages. (267 citations)
- Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure (187 citations)
- HCV direct‐acting antiviral agents: the best interferon‐free combinations (183 citations)
In his most recent research, the most cited papers focused on:
Raymond F. Schinazi mainly investigates Virology, Virus, Viral replication, Nucleoside and Molecular biology.
His research is interdisciplinary, bridging the disciplines of SAMHD1 and Virology.
His Virus research is multidisciplinary, incorporating perspectives in Nucleoside analogue, Disease reservoir and Dengue fever.
His Viral replication study integrates concerns from other disciplines, such as Hepatitis B, Interferon, Immune system, Cas9 and Cell biology.
His biological study spans a wide range of topics, including Prodrug and Polymerase.
The concepts of his Molecular biology study are interwoven with issues in SAMHD1 Protein, Protein structure, Antibody, Western blot and Viral protein.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
